Business Wire DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/70aee8/infectious_disease) has announced the addition of Decision Resources, Inc.’s new report “Infectious Disease Vaccines – Unmet Needs and Opportunities for Pharma” to their offering. “Infectious Disease Vaccines – Unmet Needs and Opportunities for Pharma” “By sheer numbers, it’s a huge pool of people that immunizations could really reach and […]
Partnering for HPV Vaccine Introduction, Part 1: Questions Unanswered
By Norma Erickson, President of SaneVax Inc. On 5 October 2005, eight months prior to FDA approval of the HPV vaccine Gardasil, the Pan American Health Organization (PAHO, a regional office of the World Health Organization) sponsored a meeting in Washington D.C. The theme of this meeting was, Partnering for HPV Vaccine Introduction. According to […]
GlaxoSmithKline Schemes with GAVI to Offer Rotavirus Vaccine at Reduced Costs to Third World
Vaccine Truth by Christina England June 7, 2011 According to an article released in the Times yesterday, the Global Alliance for Vaccines and Immunization (GAVI) have linked up none other than GlaxoSmithKline to sell cheap, left over vaccines. How the scheme works is by GAVI agreeing to purchase significant volumes of vaccines over a number […]
HPV Vaccine enhanced with an adjuvant
VIHC Vaccine Injury Help Center Posted on June 6, 2011 by Vaccine Injury Lawyer According to an article for Medical News Today, “The immune response against the virus that causes cervical cancer is stronger and sustained following vaccination with GlaxoSmithKline’s (GSK) candidate HPV vaccine formulated with the innovative AS04 adjuvant compared to using the same […]
European Medicines Agency Recommends Interim Measures For Pandemrix
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the product information for Pandemrix should be amended to advise prescribers to take into account preliminary results from epidemiological studies on Pandemrix and narcolepsy, and to perform an individual benefit-risk assessment when considering the use of Pandemrix in children and […]
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 61
- Next Page »